Age at diagnosis, glycaemic control and the development of retinopathy in a population-based cohort of Type 1 diabetic subjects in Canterbury, New Zealand
Cm. Florkowski et al., Age at diagnosis, glycaemic control and the development of retinopathy in a population-based cohort of Type 1 diabetic subjects in Canterbury, New Zealand, DIABET RE C, 52(2), 2001, pp. 125-131
The aim was to determine the relationship between age at diagnosis, glycaem
ic control and the development of retinopothy in a population-based cohort
of Type I diabetic subjects. At 1 January 1984, there were 286 individuals
with Type 1 diabetes (and age of onset < 20 years) on the Canterbury, New Z
ealand population register who had at least 2 prospective HbA(1c) readings
(from 1 January 1984). Of these, 107 already had retinopathy. Of the 179 su
bjects without retinopathy at baseline 63 developed retinopathy during foll
ow-up. After controlling for duration of diabetes: tin the whole group), ag
e at diagnosis was found to be a significant predictor of HbA(1c) level (P
= 0.001). with higher (mean <plus/minus> SD) baseline HbA(1c) in the 10-14
age group (7.95 +/- 2.14%,), compared with (7.62 +/- 1.77%) in the < 10 yea
r group and (7.39 <plus/minus> 12.57%) in the > 14 year group. The major pr
edictors of retinopathy tin those without retinopathy at baseline), however
were duration of diabetes (mean time to development of It retinopathy decr
eases by 14% (95% Cl 10 17%) for each year), baseline HbA(ac) (for each uni
t increase, mean lime to development of retinopathy decreased by 23%(95%Cl
13-32%) and HbA(1c) slope (average annual change). Peri-pubertal age at dia
gnosis(10-14 years) did not influence the lime to onset of retinopathy over
and above that attributed to duration of diabetes and glycaemic control. (
C) 2001 Elsevier Science Ireland Ltd. All rights reserved.